In addition, before therapy, serum miR-4299 and miR-16-5p expressions were significantly negatively associated with Scr, Cys-C, and KIM-1 [8, 11, 23], suggesting that their expression was promising for prediction or evaluation of adverse outcome of sepsis patients. The gene discussed is HAVCR1; the disease is Sepsis.